HK1146070A1 - 保護性皮膚護理四肽 - Google Patents

保護性皮膚護理四肽

Info

Publication number
HK1146070A1
HK1146070A1 HK11100244.1A HK11100244A HK1146070A1 HK 1146070 A1 HK1146070 A1 HK 1146070A1 HK 11100244 A HK11100244 A HK 11100244A HK 1146070 A1 HK1146070 A1 HK 1146070A1
Authority
HK
Hong Kong
Prior art keywords
tetrapeptides
skin care
protective skin
protective
care
Prior art date
Application number
HK11100244.1A
Other languages
English (en)
Inventor
Lijuan Zhang
Scott M Harris
Timothy J Falla
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Publication of HK1146070A1 publication Critical patent/HK1146070A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK11100244.1A 2007-10-29 2011-01-11 保護性皮膚護理四肽 HK1146070A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81507P 2007-10-29 2007-10-29
PCT/US2008/012191 WO2009058244A1 (en) 2007-10-29 2008-10-28 Protective skin care tetrapeptides

Publications (1)

Publication Number Publication Date
HK1146070A1 true HK1146070A1 (zh) 2011-05-13

Family

ID=40305326

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11100244.1A HK1146070A1 (zh) 2007-10-29 2011-01-11 保護性皮膚護理四肽

Country Status (10)

Country Link
US (1) US8071555B2 (zh)
EP (1) EP2205623B1 (zh)
JP (1) JP5379806B2 (zh)
KR (1) KR101668803B1 (zh)
CN (1) CN101855235B (zh)
CA (1) CA2701420C (zh)
ES (1) ES2567706T3 (zh)
HK (1) HK1146070A1 (zh)
PL (1) PL2205623T3 (zh)
WO (1) WO2009058244A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7989160B2 (en) 2006-02-13 2011-08-02 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
PL2065029T3 (pl) * 2007-11-30 2013-09-30 Evonik Degussa Gmbh Kompozycja do higieny osobistej i kosmetyczna, zawierająca tetrapeptydy z motywami GX1X2G, PX1X2P lub PX1X2K
KR102140169B1 (ko) 2011-06-24 2020-07-31 노노 인코포레이티드 허혈에 대한 psd-95 억제제와의 조합 요법
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
BR112014025621B1 (pt) * 2012-04-16 2023-01-17 Lubrizol Advanced Materials, Inc Composto, composição cosmética ou farmacêutica, e, uso de um composto
CN104507969A (zh) 2012-07-19 2015-04-08 阿莱斯亚生物疗法股份有限公司 抗siglec-15抗体
AU2014278708B2 (en) 2013-06-14 2017-12-07 Helix Biomedix, Inc. Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions
KR20150130616A (ko) * 2014-05-13 2015-11-24 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
US9636292B2 (en) 2015-07-30 2017-05-02 Truth Aesthetics LLC Topical skin care composition for night use
US9351911B1 (en) 2015-07-30 2016-05-31 Truth Aesthetics LLC Topical skin care composition providing broad spectrum sunscreen
CN107629111B (zh) * 2017-10-26 2021-06-04 陕西慧康生物科技有限责任公司 一种乙酰基四肽-2的液相合成方法
EP3887389A4 (en) * 2018-11-30 2022-10-19 InterK Peptide Therapeutics Limited POLYPEPTIDES AND METHODS FOR RELIEVING SKIN CONDITIONS
KR102120992B1 (ko) * 2019-05-03 2020-06-10 (주)위바이오트리 신규한 금속 층상수산화물 복합체 및 이의 제조방법
IT201900008364A1 (it) * 2019-06-07 2020-12-07 Espikem S R L Peptidi bioattivi e composizioni che li comprendono
EP4001294A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
FR3123193A1 (fr) * 2021-05-28 2022-12-02 L'oreal Procédé d’électroporation pour délivrer une composition comprenant au moins un peptide de poids moléculaire allant de 500 Da à 20 kDa
WO2023212090A1 (en) * 2022-04-27 2023-11-02 Sbla Brands Inc. Anti-aging peptide containing cosmetic

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA946837A (en) * 1970-07-28 1974-05-07 Miguel A. Ondetti Enzyme inhibitor
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
EP0365655B1 (en) 1988-04-21 1994-09-21 Uab Research Foundation Bioelastomeric materials suitable for the protection of wound repair sites from the occurrence of adhesions
WO1990012866A1 (en) 1989-04-10 1990-11-01 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5464820A (en) * 1993-06-22 1995-11-07 The University Hospital Specific inhibitors of tissue kallikrein
US5763576A (en) * 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
EP0858808B1 (en) 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptides for use in wound treatment
GB9702943D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Wound healing
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
US6143742A (en) * 1997-12-11 2000-11-07 Fuisz Technologies Ltd Treatment for necrotizing infections
US6962904B1 (en) * 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6344189B1 (en) * 1998-04-01 2002-02-05 Biotech Australia Pty., Ltd. Use of protease inhibitors for treating skin wounds
US6096327A (en) * 1998-11-05 2000-08-01 Protease Sciences Inc. Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
CA2312075A1 (en) * 1998-11-05 2001-12-22 Protease Sciences, Incorporated Cosmetic compositions containing human type serine protease inhibitors
FR2788777B1 (fr) * 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
US6492326B1 (en) * 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6284802B1 (en) * 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
CA2276542C (en) 1999-06-28 2013-07-30 Vladislav I. Deigin Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6537968B1 (en) * 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
GB0029777D0 (en) * 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
CA2441562C (en) 2001-03-28 2013-05-14 Helix Biomedix, Inc. Short bioactive peptides and methods for their use
WO2002092623A1 (en) * 2001-05-11 2002-11-21 Research Development Foundation INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
US20040167072A1 (en) * 2001-05-11 2004-08-26 Aggarwal Bharat B. Inhibitors of receptor activator of NF-kappaB and uses thereof
US7238656B2 (en) * 2001-08-29 2007-07-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective factors against inflammation, burns and noxious stimuli
US7041506B2 (en) * 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
US20030175745A1 (en) * 2001-11-28 2003-09-18 Dean Cheryl H. Peptides with growth inhibitory action
US20040009911A1 (en) * 2002-01-31 2004-01-15 Irm, Llc Hepsin substrates and prodrugs
WO2003093314A2 (en) * 2002-05-03 2003-11-13 Millenium Biologix Inc. Connective tissue stimulating peptides
US7265097B2 (en) * 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
US7541440B2 (en) * 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
KR101045658B1 (ko) * 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물
DE102004050563A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort
DE202004012807U1 (de) 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden
DE102005000868A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren
DE102004055541A1 (de) 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
US7271239B2 (en) * 2004-09-01 2007-09-18 The Research Foundation Of State University Of New York D-isomers of antimicrobial peptide
US20060046271A1 (en) * 2004-09-02 2006-03-02 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
US20070224150A1 (en) * 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
FR2884418B1 (fr) 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
KR20080033331A (ko) * 2005-07-05 2008-04-16 바이오템프트, 비.브이. 종양 치료제
US20070077305A1 (en) * 2005-10-03 2007-04-05 Le Tien C Biocompatible polymeric matrix and preparation thereof
DE102005063062A1 (de) 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
US7807625B2 (en) * 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition
CA2642748C (en) * 2006-02-21 2017-03-07 President And Fellows Of Harvard College Compositions for and methods of identifying antigens

Also Published As

Publication number Publication date
JP5379806B2 (ja) 2013-12-25
WO2009058244A1 (en) 2009-05-07
CN101855235B (zh) 2013-04-24
CN101855235A (zh) 2010-10-06
EP2205623A1 (en) 2010-07-14
US8071555B2 (en) 2011-12-06
JP2011502121A (ja) 2011-01-20
KR101668803B1 (ko) 2016-10-24
PL2205623T3 (pl) 2016-09-30
ES2567706T3 (es) 2016-04-26
CA2701420A1 (en) 2009-05-07
EP2205623B1 (en) 2016-03-16
KR20100083828A (ko) 2010-07-22
US20090142280A1 (en) 2009-06-04
CA2701420C (en) 2016-02-09

Similar Documents

Publication Publication Date Title
HK1146070A1 (zh) 保護性皮膚護理四肽
TWI348920B (en) Whitening agent and skin care agent
PL2059223T3 (pl) Kompozycja do pielęgnacji skóry
PL2278952T3 (pl) Środki do czyszczenia skóry i rąk
IL208458A0 (en) Compositions and methods for skin care
EP2461765A4 (en) COSMETIC REJUVENATION OF THE SKIN
EP2222270A4 (en) COLLAGEN FORMULATIONS FOR ENHANCED SKIN CARE
EP2168568A4 (en) SKIN COSMETICS
GB0708938D0 (en) Skin care composition
GB0716605D0 (en) Skin antiseptics
EP2127634A4 (en) COMPOSITION FOR SKIN OR HAIR
EP2135596A4 (en) HAIR CARE COMPOSITIONS
HK1115798A1 (en) Skin care device
EP2221046A4 (en) SKIN CARE PREPARATIONS
PT2200624T (pt) Bagas de góji e inflamação da pele
HK1137135A1 (en) Skin care device
GB0719202D0 (en) Compositions and methods for the skin and hair
GB0702931D0 (en) Skin application
GB0606921D0 (en) Skin dressing
EP2225962A4 (en) HAIR CARE DEVICE
EP2042153A4 (en) skin cosmetic
EP2165699A4 (en) CAPILLARY COSMETICS
EP2156820A4 (en) SKIN WHITENING AGENT
HUP0800340D0 (en) Device for skin care with light-therapy
TWI371289B (en) Mixture for skin care